Wen (Maxwell) Wang is the founder of IASO Biotherapeutics. IASO Biotherapeutics has raised $178M in total funding. Latest round: Series C.
Dr. Wen (Maxwell) Wang is the Founder and CEO of IASO Biotherapeutics, a clinical-stage biopharmaceutical company focused on cell therapies and biologics for oncology and autoimmune diseases. He leads the company's global operations across sites in Nanjing, Shanghai, California, and New Jersey.
Full founder directory · Investor directory · Company funding database · Fundraising library